Cryopreservation as an Alternative Approach for Applying Photopheresis Products to Treat Graft‐Versus‐Host Disease ( <scp>GVHD</scp> ) Among Pediatric Patients in Developing Countries
Cryopreserving MNCs for ECP in pediatric patients with steroid-resistant GvHD is a practical and effective method to overcome existing limitations. We propose that cryopreservation could be a more effective option than repeated apheresis for pediatric patients and in developing countries, as it reduces costs and eliminates the need for multiple apheresis sessions.
Authors
- Fahimeh Jafari (ORCID: https://orcid.org/0000-0003-3847-3092)
- Sarina Ansari
- Maryam Behfar (ORCID: https://orcid.org/0000-0001-9473-3632)
- Amir Ali Hamidieh (ORCID: https://orcid.org/0000-0002-8935-079X)
- Hamid Farajifard (ORCID: https://orcid.org/0000-0002-4500-5855)
- Leila Jafari (ORCID: https://orcid.org/0000-0001-6838-2963)
- Mona Delkhah
- Yalda Karamlou
- Rashin Mohseni
- Pooya Ashkevari
- Homa Kashani (ORCID: https://orcid.org/0000-0001-7935-460X)
- Mohamad Taha Salmanifard
- Nika Asephi
Institutions
- Gene Therapy Laboratory (FR)
- Children's Medical Center (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Pediatric Transplantation
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1111/petr.70208
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00